HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Christoffersen Selected Research

Uterine Prolapse (Vaginal Prolapse)

3/2003Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Christoffersen Research Topics

Disease

1Fibrosis (Cirrhosis)
02/2006
1Atherosclerosis
01/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2003
1Heart Failure
06/2003
1Uterine Prolapse (Vaginal Prolapse)
03/2003
1Postmenopausal Osteoporosis
03/2003
1Edema (Dropsy)
03/2003
1Urinary Incontinence
03/2003

Drug/Important Bio-Agent (IBA)

1Atrial Natriuretic Factor (ANF)IBA
02/2006
1Natriuretic PeptidesIBA
02/2006
1Lipoproteins (Lipoprotein)IBA
01/2006
1Brain Natriuretic Peptide (Natrecor)FDA Link
06/2003
1levormeloxifeneIBA
03/2003

Therapy/Procedure

1Therapeutics
06/2003